Author

Michaela Jackson

Ionis Pharmaceuticals (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Armand SorianoiD· 1 shared C. Frank BennettiD· 1 shared Daniel A Norris· 1 shared Eric E. SwayzeiD· 1 shared Frank RigoiD· 1 shared Gemma BachmanniD· 1 shared Jinghua YuiD· 1 shared John L. HunyaraiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Armand SorianoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhanced splicing modulation by NMA-modified antisense oligonucleotides

Karen Ling, Thazha P. Prakash, Jinghua Yu, Michaela Jackson, Seung Joo Chun, Gemma Bachmann, Noah M. Post, Sarah Greenlee, Armand Soriano, John L. Hunyara, Daniel A Norris, Paymaan Jafar‐Nejad, Eric E. Swayze, C. Frank Bennett, Frank Rigo

This paper introduces NMA-modified antisense oligonucleotides that show improved potency compared to MOE-modified SSOs in modulating splicing for SMA and Dravet syndrome.

Nucleic Acids Research · May 2, 2026Peer-reviewedPharmacology & Toxicology